Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
89Zr-NY009 PET Imaging in Cancer
NCT05691855Phase 1Unknown
- Sponsor
- Affiliated Hospital of Jiangnan University
- Start
- Jun 2022
- Primary completion
- Jun 2023
- Modality
- PET (Positron Emission Tomography)
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 89Zr-NY009 in cancer, sponsored by Affiliated Hospital of Jiangnan University. Primary endpoint: Evaluation of tissue distribution of 89Zr-NY009 at 7 days. Status: unknown.
02
Drugs
89Zr-NY009
03
Conditions
cancer
Beyond the preview
Go deeper on NCT05691855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05691855.